|
US6074650A
(en)
|
1985-06-24 |
2000-06-13 |
Hoechst Aktiengesellschaft |
Membrane anchor/active compound conjugate, its preparation and its uses
|
|
AU5186090A
(en)
|
1989-02-23 |
1990-09-26 |
Colorado State University Research Foundation |
Gnrh analogs for destroying gonadotrophs
|
|
US6214345B1
(en)
|
1993-05-14 |
2001-04-10 |
Bristol-Myers Squibb Co. |
Lysosomal enzyme-cleavable antitumor drug conjugates
|
|
US6106834A
(en)
|
1993-06-02 |
2000-08-22 |
Research Corporation Technologies, Inc. |
Use of anti-CD45 leukocyte antigen antibodies for immunomodulation
|
|
US6024957A
(en)
|
1993-06-02 |
2000-02-15 |
Research Corporation Technologies, Inc. |
Immunomodulators and methods for the prevention and reversal of organ transplant rejection using same
|
|
GB9323199D0
(en)
|
1993-11-10 |
1994-01-05 |
Falkenberg J H F |
Leukaemia treatment
|
|
US6759509B1
(en)
|
1996-11-05 |
2004-07-06 |
Bristol-Myers Squibb Company |
Branched peptide linkers
|
|
US20110045005A1
(en)
|
2001-10-19 |
2011-02-24 |
Craig Crowley |
Compositions and methods for the treatment of tumor of hematopoietic origin
|
|
AU2002351204B2
(en)
*
|
2001-12-03 |
2008-07-10 |
Abgenix, Inc. |
Anti-CD45RB antibodies for use in treating autoimmune disease and transplant rejection
|
|
HRP20100334T1
(hr)
*
|
2003-09-18 |
2010-07-31 |
Novartis Ag |
Terapeutska humanizirana antitijela protiv cd45-izoforma
|
|
EP1718667B1
(en)
|
2004-02-23 |
2013-01-09 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
EP1661584A1
(en)
|
2004-11-26 |
2006-05-31 |
Heinz Dr. Faulstich |
Use of conjugates of amatoxins and phallotoxins with macromolecules for cancer and inflammation therapy
|
|
US7947839B2
(en)
|
2004-12-01 |
2011-05-24 |
Genentech, Inc. |
Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
|
|
WO2007087453A2
(en)
|
2006-01-27 |
2007-08-02 |
Cellerant Therapeutics, Inc. |
Compositions and methods for treating haematological proliferative disorders
|
|
JP2009529522A
(ja)
|
2006-03-10 |
2009-08-20 |
ディアト |
酵素で切断可能なリンカーを介して抗体に複合された抗癌剤
|
|
ES2371085T3
(es)
|
2006-05-27 |
2011-12-27 |
Faulstich, Heinz, Dr. |
Utilización de conjugados de amatoxinas o falotoxinas con macromoléculas para la terapia tumoral y de la inflamación.
|
|
ES2567402T3
(es)
|
2006-05-30 |
2016-04-22 |
Genentech, Inc. |
Anticuerpos anti CD22, sus inmunoconjugados y usos de los mismos
|
|
CA2683137A1
(en)
*
|
2006-10-10 |
2008-04-17 |
Squicor |
Compositions and methods for treating and diagnosing cancers
|
|
ES2882360T3
(es)
*
|
2006-11-03 |
2021-12-01 |
Univ Leland Stanford Junior |
Inmunoempobrecimiento selectivo de un nicho de células madre endógenas para injerto
|
|
WO2008070593A2
(en)
|
2006-12-01 |
2008-06-12 |
Seattle Genetics, Inc. |
Variant target binding agents and uses thereof
|
|
MX2011010265A
(es)
*
|
2009-04-01 |
2011-10-11 |
Genentech Inc |
Anticuerpos anti-fcrh5 e inmunoconjugados y metodos de uso.
|
|
JP2012523383A
(ja)
*
|
2009-04-08 |
2012-10-04 |
ファウルシュティヒ，ハインツ |
がんの治療のためのアマトキシンと複合体形成した標的結合部分
|
|
US9233173B2
(en)
|
2009-04-08 |
2016-01-12 |
Deutsches Krebsforschungszentrum |
Amatoxin-armed therapeutic cell surface binding components designed for tumour therapy
|
|
MX391454B
(es)
|
2010-04-15 |
2025-03-05 |
Seagen Inc |
Compuesto de engarce-fármaco para conjugación a una unidad de ligando.
|
|
ES2402254T3
(es)
|
2010-09-30 |
2013-04-30 |
Heidelberg Pharma Ag |
Conjugados de amatoxinas con ligadores mejorados
|
|
EP2497499A1
(en)
|
2011-03-10 |
2012-09-12 |
Heidelberg Pharma GmbH |
Amatoxin-conjugates with improved linkages
|
|
CN110200997A
(zh)
*
|
2011-03-23 |
2019-09-06 |
弗雷德哈钦森癌症研究中心 |
用于细胞免疫治疗的方法和组合物
|
|
HUE045348T2
(hu)
|
2011-05-08 |
2019-12-30 |
Legochem Biosciences Inc |
Fehérje-hatóanyag konjugátumok és eljárás elõállításukra
|
|
WO2013055993A1
(en)
|
2011-10-14 |
2013-04-18 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
CN103998449A
(zh)
|
2011-10-14 |
2014-08-20 |
斯皮罗根有限公司 |
吡咯并苯并二氮杂卓
|
|
JP2015502397A
(ja)
|
2011-12-23 |
2015-01-22 |
ファイザー・インク |
部位特異的コンジュゲーションのための操作された抗体定常領域、ならびにそのための方法および使用
|
|
US9504756B2
(en)
|
2012-05-15 |
2016-11-29 |
Seattle Genetics, Inc. |
Self-stabilizing linker conjugates
|
|
EP2684865A1
(en)
|
2012-07-13 |
2014-01-15 |
Heidelberg Pharma GmbH |
Methods for synthesizing amatoxin building block and amatoxins
|
|
US20150218220A1
(en)
|
2012-09-12 |
2015-08-06 |
Brian Alan MENDELSOHN |
Amatoxin derivatives and cell-permeable conjugates thereof as inhibitors of rna polymerase
|
|
US9324898B2
(en)
*
|
2012-09-25 |
2016-04-26 |
Alliance For Sustainable Energy, Llc |
Varying cadmium telluride growth temperature during deposition to increase solar cell reliability
|
|
ES2732574T3
(es)
|
2012-11-30 |
2019-11-25 |
Novartis Ag |
Métodos para preparar conjugados a partir de proteínas que contienen disulfuro
|
|
JP2016516672A
(ja)
|
2013-02-28 |
2016-06-09 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
幹細胞を動員するための方法および組成物
|
|
EP2774624A1
(en)
|
2013-03-04 |
2014-09-10 |
Heidelberg Pharma GmbH |
Amatoxin derivatives
|
|
EP2968591A1
(en)
*
|
2013-03-15 |
2016-01-20 |
Novartis AG |
Cell proliferation inhibitors and conjugates thereof
|
|
EP2777714A1
(en)
|
2013-03-15 |
2014-09-17 |
NBE-Therapeutics LLC |
Method of producing an immunoligand/payload conjugate by means of a sequence-specific transpeptidase enzyme
|
|
US9803002B2
(en)
|
2013-05-31 |
2017-10-31 |
Genentench, Inc. |
Anti-wall teichoic antibodies and conjugates
|
|
US11229711B2
(en)
|
2013-06-06 |
2022-01-25 |
Magenta Therapeutics, Inc. |
Linkers for antibody-drug conjugates and related compounds, compositions, and methods of use
|
|
AU2014299561B2
(en)
|
2013-06-24 |
2017-06-08 |
Ablbio |
Antibody-drug conjugate having improved stability and use thereof
|
|
FR3008408B1
(fr)
|
2013-07-11 |
2018-03-09 |
Mc Saf |
Nouveaux conjugues anticorps-medicament et leur utilisation en therapie
|
|
CN105377304B
(zh)
*
|
2014-03-10 |
2018-05-15 |
海德堡医药有限责任公司 |
鹅膏毒肽衍生物
|
|
CA2950155C
(en)
|
2014-06-02 |
2021-11-23 |
Regeneron Pharmaceuticals, Inc. |
Biologically active molecule conjugates, reagents and methods of manufacture, and therapeutic uses
|
|
EP3174902B1
(en)
*
|
2014-08-01 |
2019-04-17 |
Institut National de la Sante et de la Recherche Medicale (INSERM) |
An anti-cd45rc antibody for use as drug
|
|
JP6863888B2
(ja)
|
2014-10-01 |
2021-04-21 |
メディミューン，エルエルシー |
ポリペプチドをコンジュゲートさせる方法
|
|
EP3209334A2
(en)
|
2014-10-20 |
2017-08-30 |
Igenica Biotherapeutics, Inc. |
Novel antibody-drug conjugates and related compounds, compositions, and methods of use
|
|
EP3215519A1
(en)
*
|
2014-11-06 |
2017-09-13 |
Novartis AG |
Amatoxin derivatives and conjugates thereof as inhibitors of rna polymerase
|
|
EP3026060A1
(en)
*
|
2014-11-26 |
2016-06-01 |
Miltenyi Biotec GmbH |
Humanized antibody or fragment thereof specific for CD45R0
|
|
US9729129B2
(en)
*
|
2014-12-05 |
2017-08-08 |
Bhaskar Gopalan |
System and method for reducing metastability in CMOS flip-flops
|
|
US20160220687A1
(en)
|
2015-02-02 |
2016-08-04 |
National Guard Health Affairs |
Metalloproteinase-cleavable alpha-amanitin-dendrimer conjugates and method of treating cancer
|
|
JP6863900B2
(ja)
|
2015-03-09 |
2021-04-21 |
ハイデルベルク ファルマ リサーチ ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規アマトキシン−抗体コンジュゲート
|
|
HK1249534A1
(zh)
*
|
2015-04-06 |
2018-11-02 |
哈佛大学校长及研究员协会 |
用於非清髓性预处理的组合物和方法
|
|
EP3297684B1
(en)
|
2015-05-21 |
2020-12-23 |
Actinium Pharmaceuticals, Inc. |
Infusion administration of conjugated monoclonal antibodies
|
|
WO2017051249A1
(en)
|
2015-09-25 |
2017-03-30 |
Legochem Biosciences, Inc. |
Compositions and methods related to anti-cd19 antibody drug conjugates
|
|
EP3362100B1
(en)
|
2015-10-16 |
2022-06-22 |
Genentech, Inc. |
Hindered disulfide drug conjugates
|
|
US10723766B2
(en)
|
2015-11-27 |
2020-07-28 |
Heidelberg Pharma Research Gmbh |
Derivatives of gamma-amanitin
|
|
EP3222292A1
(en)
|
2016-03-03 |
2017-09-27 |
Heidelberg Pharma GmbH |
Amanitin conjugates
|
|
HUE071169T2
(hu)
|
2016-03-07 |
2025-08-28 |
Actinium Pharmaceuticals Inc |
Stabilizált, radioaktívan jelölt anti-CD45 immunglobulin-készítmények
|
|
CA3016172C
(en)
|
2016-04-20 |
2024-03-12 |
Hangzhou Dac Biotech Co., Ltd |
Derivatives of amanita toxins and their conjugation to a cell binding molecule
|
|
US10464969B2
(en)
|
2016-05-05 |
2019-11-05 |
Novartis Ag |
Amatoxin derivatives and conjugates thereof as inhibitors of RNA polymerase
|
|
EP3464363A1
(en)
|
2016-05-27 |
2019-04-10 |
Actinium Pharmaceuticals, Inc. |
Low dose antibody-based methods for treating hematologic malignancies
|
|
EP3471771A4
(en)
|
2016-05-31 |
2020-04-15 |
Sorrento Therapeutics, Inc. |
ANTIBODY-MEDICINE CONJUGATES WITH DERIVATIVES OF AMATOXIN AS A MEDICINAL PRODUCT
|
|
BR112018076306A2
(pt)
|
2016-06-17 |
2019-03-26 |
Magenta Therapeutics, Inc. |
composições e métodos para a supressão de células cd117+
|
|
EP3500663A1
(en)
|
2016-08-29 |
2019-06-26 |
PDI Pharm Development International AG |
Provision of a therapeutically active cell product
|
|
US10112266B2
(en)
*
|
2016-09-09 |
2018-10-30 |
Baltic Innovation Holding PRO, AS |
Pressed thermite rod for a self-contained portable cutting device
|
|
EP3526260A4
(en)
*
|
2016-10-13 |
2020-11-18 |
President and Fellows of Harvard College |
NON-MYELOABLATIVE PACKAGING COMPOSITIONS AND METHODS
|
|
US11446388B2
(en)
|
2016-12-23 |
2022-09-20 |
Heidelberg Pharma Research Gmbh |
Amanitin antibody conjugates
|
|
MX395639B
(es)
|
2017-01-20 |
2025-03-25 |
Heidelberg Pharma Res Gmbh |
Composiciones y métodos para el agotamiento de células cd137+.
|
|
JP7321934B2
(ja)
|
2017-01-30 |
2023-08-07 |
ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー |
幹細胞移植のための非遺伝毒性移植前処置レジメン
|
|
WO2019030171A1
(en)
|
2017-08-07 |
2019-02-14 |
Heidelberg Pharma Gmbh |
NOVEL METHOD FOR SYNTHESIZING AMANITINES
|